Insights Care Magazine research team featured Novotech CRO in the May 2019 cover story “The 10 Companies Booming in Healthcare Sector”.
As part of the research report feature the magazine said:
“Novotech is internationally recognized as the leading regional full-service contract research organization (CRO) in Asia-Pacific and is dedicated to supporting biotech companies in their drug development by tapping into the benefits of the region. With a focus on clinical monitoring, it has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.
These include feasibility assessments, ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, and project and vendor management. The company’s strong Asia Pacific presence includes running clinical trials in all key regional markets. It also has worldwide reach through the company's network of strategic partners.
Moreover, Asia-Pacific was the fastest growing region for biotech-sponsored trials again last year, with an increase of about 35% compared with 2017. In the year 2018, Novotech maintained its focus on bringing in and retaining the best people, nurturing relationships with clients, investigators and partners, and brand development initiatives.
The customers of the company value its leadership as a Regional CRO specialist, who can understand local cultures, customs, regulations, and have developed deep relationships with the key investigators in the region.”
As part of the interview Dr Moller said:
“Novotech is focused on delivering world-class clinical services in the Asia-Pacific region for the biotech sector. We offer the very latest in Oracle and Medidata technology, and all our projects are measured on quality of service and customer satisfaction throughout every stage of our engagement.”
Novotech has offices in 11 countries across the region, and MOUs with major health providers.
About Novotech - https://novotech-cro.com/welcome
Headquartered in Sydney, Novotech is internationally recognised as the leading regional full-service contract research organisation (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech’s strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.
For RFP enquiries: Please fill out the form available at www.novotech-cro.com/contact-us